JPRN-UMIN000013975已完成未知
Intravitreal injection of anti vascular endothelial growth factor agent, Lucentis (ranibizumab), for the treatment of retinopathy of prematurity - IVR for ROP
agoya University hospital ophtalmoligy0 个研究点目标入组 30 人开始时间: 2014年5月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 0years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •inflammation around the eye
研究者
相似试验
已完成
不适用
Vitreous injection of anti vascular endothelium growth factor for macular edema.JPRN-UMIN000012094Mie University Schoolof Medicine100
尚未招募
不适用
Intravitreal aflibercept injection for exudative age-related macular degeneratioAge-Related Macular DegenerationJPRN-UMIN000010997Department of Ophthalmology, Fukushima Medical University School of Medicine50
招募中
1 期
eovascular glaucoma prevention by intravitreal injections of anti-VEGF in patients treated by protontherapy in case of large choroidal melanomaEUCTR2016-003329-40-FRCHU de Nice56
已完成
不适用
Combination therapy with intravitreal tissue plasminogen activator and ranibizumab for subfoveal type 2 choroidal neovascularizatioSubfoveal type 2 choroidal neovascularizationJPRN-UMIN000016870agoya City University Graduate School of Medicine20
尚未招募
Unknown
A clinical study to determine the safety and performance of Everads Injector for Injection of triamcinolone acetonide in suprachoroidal space of eye.CTRI/2024/01/061410Everads Therapy Ltd.